Expert Consensus on the Clinical Application of Thymosin Alpha 1 in Infectious Diseases and Critical Care Medicine
Abstract. As immunotherapy gains increasing attention and clinical application, the immune modulation therapy has been widely used in the treatment of infectious and critical diseases. Clinical evidence has been accumulated for application of thymosin alpha 1 (Tα1), a classical immune modulator, in...
Saved in:
| Format: | Article |
|---|---|
| Language: | English |
| Published: |
Wolters Kluwer Health
2025-06-01
|
| Series: | Infectious Microbes & Diseases |
| Online Access: | http://journals.lww.com/10.1097/IM9.0000000000000176 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expert consensus for smoking cessation with metaverse in medicine
by: Lian Wu, et al.
Published: (2024-12-01) -
Expert Consensus on Rare Disease Pharmaceutical Care in Hospitals (2025)
by: Rare Disease Drug Committee of the Chinese Pharmaceutical Association
Published: (2025-05-01) -
Expert Consensus on Clinical Application of Lower Limb Rehabilitation Robots
by: ZHANG Lixin, et al.
Published: (2023-10-01) -
The Clinical Relevance and Functional Implications of Thymosin Beta-10 in Glioma
by: Weimin Li, et al.
Published: (2023-01-01) -
Chinese expert consensus on the application of intravenous immunoglobulin in hematological diseases
by: Zhi Guo, et al.
Published: (2025-04-01)